BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report) shares traded up 3.9% during trading on Thursday . The company traded as high as $1.88 and last traded at $1.85. 50,428 shares changed hands during trading, a decline of 100% from the average session volume of 62,169,492 shares. The stock had previously closed at $1.78.
BioRestorative Therapies Stock Performance
The firm has a fifty day moving average of $1.95 and a 200 day moving average of $1.73. The firm has a market capitalization of $3.03 billion, a PE ratio of -1.73 and a beta of 102.36.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Featured Stories
- Five stocks we like better than BioRestorative Therapies
- Trading Stocks: RSI and Why it’s Useful
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- How to Short a Stock in 5 Easy Steps
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- What Are Dividends? Buy the Best Dividend Stocks
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
